Survival Analysis of 272 Patients With Pancreatic Cancer Undergoing Combined Treatment

Conclusions: KPS was an important prognostic factor of pancreatic cancer. Spleen-invigorating compounds could have an effect on improving the prognosis of pancreatic cancer patients

Source: Integrative Cancer Therapies - February 12, 2015 Category: Cancer & Oncology Authors: Cao, N., Zhao, A., Zhao, G., Wang, X., Han, B., Lin, R., Zhao, Y., Yang, J. Tags: Research Articles Source Type: research